TY - JOUR
T1 - Advanced MR Techniques for Preoperative Glioma Characterization
T2 - Part 1
AU - Hirschler, Lydiane
AU - Sollmann, Nico
AU - Schmitz-Abecassis, Bárbara
AU - Pinto, Joana
AU - Arzanforoosh, Fatemehsadat
AU - Tseng, Chih Hsien
AU - Vos, Frans
AU - Warnert, Esther
AU - Smits, Marion
AU - More Authors, null
PY - 2023
Y1 - 2023
N2 - Preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this first part, we discuss dynamic susceptibility contrast and dynamic contrast-enhanced MRI, arterial spin labeling, diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting. The second part of this review addresses magnetic resonance spectroscopy, chemical exchange saturation transfer, susceptibility-weighted imaging, MRI-PET, MR elastography, and MR-based radiomics applications. Evidence Level: 3. Technical Efficacy: Stage 2.
AB - Preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this first part, we discuss dynamic susceptibility contrast and dynamic contrast-enhanced MRI, arterial spin labeling, diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting. The second part of this review addresses magnetic resonance spectroscopy, chemical exchange saturation transfer, susceptibility-weighted imaging, MRI-PET, MR elastography, and MR-based radiomics applications. Evidence Level: 3. Technical Efficacy: Stage 2.
KW - brain
KW - contrasts
KW - GliMR 2.0
KW - glioma
KW - level of clinical validation
KW - preoperative
UR - http://www.scopus.com/inward/record.url?scp=85149469575&partnerID=8YFLogxK
U2 - 10.1002/jmri.28662
DO - 10.1002/jmri.28662
M3 - Review article
AN - SCOPUS:85149469575
SN - 1053-1807
VL - 57
SP - 1655
EP - 1675
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 6
ER -